YAP1 and colorectal carcinoma: We speculate that miR-375 may fulfill regulatory drug resistance function in the majority of malignant cancer cells, whereas it seems to be blurry about how miR-375 modulates the therapeutic resistance of CRC cells by targeting YAP1.